Liquidia Technologies Inc (LQDA)

Liquidia Technologies Inc (LQDA) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $3.6B; returns 1 day +7.5%, 1 week +24.2%, 1 year +93.7%.

Liquidia Corporation (NASDAQ: LQDA) is a biopharmaceutical company focused on developing and commercializing therapies for cardiopulmonary diseases, particularly pulmonary hypertension.

Groups LQDA belongs to

• Biotechnology
• Biopharmaceutical
• Healthcare
• Cardiovascular Therapies
• Commercial Stage Biotech
• Life Sciences
• Pharmaceuticals
• Drug Discovery
• Clinical Stage Biopharma

LQDA financial model: income statement, cash flow and balance sheet